Detalhe da pesquisa
1.
Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination.
Vaccines (Basel)
; 11(2)2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851122
2.
Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine.
Viruses
; 15(9)2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766332
3.
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine.
Cell Rep
; 42(1): 111998, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656710
4.
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells.
iScience
; 26(1): 105904, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594081
5.
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile.
Cell Rep Med
; 4(3): 100955, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863335
6.
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses.
Cell Rep
; 41(4): 111554, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244343
7.
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses.
Cell Host Microbe
; 30(1): 97-109.e5, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953513
8.
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.
Cell Rep
; 39(13): 111013, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732172
9.
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses.
Cell Rep
; 38(9): 110429, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216664
10.
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
Cell Rep Med
; 2(6): 100290, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33969322
11.
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
bioRxiv
; 2021 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532774
12.
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.
bioRxiv
; 2021 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981046
13.
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.
Cell Host Microbe
; 29(7): 1137-1150.e6, 2021 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133950
14.
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses.
bioRxiv
; 2021 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758857
15.
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
mBio
; 11(5)2020 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067385